Title |
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.
|
---|---|
Published in |
Journal of the National Comprehensive Cancer Network (JNCCN), March 2018
|
DOI | 10.6004/jnccn.2018.0013 |
Pubmed ID | |
Authors |
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, Richard F Ambinder, Patricia Aoun, Philippe Armand, Celeste M Bello, Cecil M Benitez, Philip J Bierman, Robert Chen, Bouthaina Dabaja, Robert Dean, Andres Forero, Leo I Gordon, Francisco J Hernandez-Ilizaliturri, Ephraim P Hochberg, Jiayi Huang, Patrick B Johnston, Mark S Kaminski, Vaishalee P Kenkre, Nadia Khan, Kami Maddocks, David G Maloney, Monika Metzger, Joseph O Moore, David Morgan, Craig H Moskowitz, Carolyn Mulroney, Rachel Rabinovitch, Stuart Seropian, Randa Tao, Jane N Winter, Joachim Yahalom, Jennifer L Burns, Ndiya Ogba |
Abstract |
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN Guidelines Panel meets at least annually to review comments from reviewers within the NCCN Member Institutions, examine relevant data, and reevaluate and update the recommendations. These NCCN Guidelines Insights summarize recent updates centered on treatment considerations for relapsed/refractory classic HL. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 30% |
Spain | 3 | 30% |
Australia | 1 | 10% |
Unknown | 3 | 30% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 9 | 90% |
Practitioners (doctors, other healthcare professionals) | 1 | 10% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 35 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Doctoral Student | 4 | 11% |
Other | 3 | 9% |
Student > Bachelor | 3 | 9% |
Researcher | 3 | 9% |
Professor | 3 | 9% |
Other | 5 | 14% |
Unknown | 14 | 40% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 15 | 43% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Physics and Astronomy | 1 | 3% |
Agricultural and Biological Sciences | 1 | 3% |
Social Sciences | 1 | 3% |
Other | 1 | 3% |
Unknown | 15 | 43% |